Ticker
TVTXCompany Name
TRAVERE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 555.31M | $ 399.57M | 71.96% |
3/31/2025 | $ 548.8M | $ 400.46M | 72.97% |
12/31/2024 | $ 594.13M | $ 401.58M | 67.59% |
9/30/2024 | $ 504.41M | $ 402.43M | 79.78% |
6/30/2024 | $ 551.12M | $ 403.23M | 73.16% |
3/31/2024 | $ 663.55M | $ 404.02M | 60.89% |
12/31/2023 | $ 788.91M | $ 404.78M | 51.31% |
9/30/2023 | $ 832.85M | $ 405.48M | 48.69% |
6/30/2023 | $ 736.43M | $ 406.17M | 55.15% |
3/31/2023 | $ 808.23M | $ 406.85M | 50.34% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for TRAVERE THERAPEUTICS INC is calculated as follows: Debt [ $ 212.65M ] / Assets [ $ 692.22M ]
(=) Debt to Assets [ 30.72% ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |